Where does Inbios International, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Inbios International, Inc. ranks #29,066 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Inbios International, Inc. hold?

Inbios International, Inc. holds 9 US utility patents granted between 2016 and 2025, spanning 11 technology areas.

What is Inbios International, Inc.'s Innovation Score?

Inbios International, Inc. has an Innovation Score of 46.2 out of 100 (top 21% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Inbios International, Inc. focus on?

Inbios International, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 8 patents, ranking #1,791 of 7,863 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Inbios International, Inc.'s patent grant rate increasing or decreasing?

Inbios International, Inc.'s recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Inbios International, Inc.'s patents?

Inbios International, Inc.'s patents average 22.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Inbios International, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Inbios International, Inc.

USPTO PatentsView assignee record - 9 granted patents across 11 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Inbios ranks #29,066 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 11 technology areas.

#29,066
of 49,997 US assignees by volume: Top 21%
by Innovation Score (46.2/100): 22.0
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29066 · US Corporation #29,066 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,066/49,997
PHOTO-FINISH Impac Medical Systems
CPC-FOCUS G01N · 11 areas
INNOV-PAR 46.2/100
CLAIMS-DENSE 22.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Impac Medical Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Inbios’s 46.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (17%) Velocity 13.3 pts (29%) Breadth 11.7 pts (25%) Claim depth 13.2 pts (29%)

Qualcomm Incorporated · highest

85
Inbios International · this assignee

46
3D Lighting… · lowest

7

What this shows Inbios's Innovation Score is 46.2/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Inbios?

Each dot is one of Inbios’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Inbios’s own 22.0 claims/patent is ABOVE the 10.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Inbios vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Inbios's grants concentrate

Inbios International, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 88.9% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2016. By volume, Inbios sits between Impac Medical Systems, Inc. and Infocus Corporation.

Inbios's three-year grant acceleration

Inbios International, Inc. shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Impac Medical Sys…

9
Imsol

9
IN Ingredients

9
In-tech Enterprise

9
Incnetworks

9
Indian Council OF…

9
Industrial Fence

9
Infocus

9
Inbios Internatio… ◀

9

What this shows Inbios holds 9 patents at rank #29,043, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Inbios

By rank, the assignees closest to #29,043 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Inbios's primary technology class.

Inbios's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 21% higher than 79% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Inbios International, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	11.1%
2018	1	11.1%
2021	2	22.2%
2023	1	11.1%
2024	3	33.3%
2025partial year	1	11.1%

Which technologies does Inbios International, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

C07K - Peptides 5

Y02A - Technologies FOR Adaptation TO Climate Change 5

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 2

G06T - Image Data Processing OR Generation, IN General 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

A61B - DIAGNOSIS; SURGERY; Identification 1

G06V - Image OR Video Recognition OR Understanding 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Inbios International, Inc.'s patent record in context - here's where to go next.

Inbios International, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 88.9% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #29,066 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Inbios International, Inc. against Impac Medical Systems, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.